首页> 外文期刊>Journal of applied microbiology >Potent anti-mycobacterial and immunomodulatory activity of some bioactive molecules of Indian ethnomedicinal plants that have the potential to enter in TB management
【24h】

Potent anti-mycobacterial and immunomodulatory activity of some bioactive molecules of Indian ethnomedicinal plants that have the potential to enter in TB management

机译:印度民族药用植物的某些生物活性分子具有有效的抗分枝杆菌和免疫调节活性,这些分子有可能进入结核病管理领域

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Tuberculosis (TB) is one of the deadliest infectious diseases of human civilization. Approximately one-third of global population is latently infected with the TB pathogen Mycobacterium tuberculosis (M.tb). The discovery of anti-TB antibiotics leads to decline in death rate of TB. However, the evolution of antibiotic-resistant M.tb-strain and the resurgence of different immune-compromised diseases re-escalated the death rate of TB. WHO has already cautioned about the chances of pandemic situation in TB endemic countries until the discovery of new anti-tubercular drugs, that is, the need of the hour. Analysing the pathogenesis of TB, it was found that M.tb evades the host by altering the balance of immune response and affects either by killing the cells or by creating inflammation. In the pre-antibiotic era, traditional medicines were only therapeutic measures for different infectious diseases including tuberculosis. The ancient literatures of India or ample Indian traditional knowledge and ethnomedicinal practices are evidence for the treatment of TB using different indigenous plants. However, in the light of modern scientific approach, anti-TB effects of those plants and their bioactive molecules were not established thoroughly. In this review, focus has been given on five bioactive molecules of different traditionally used Indian ethnomedicinal plants for treatment of TB or TB-like symptom. These compounds are also validated with proper identification and their mode of action with modern scientific approaches. The effectiveness of these molecules for sensitive or drug-resistant TB pathogen in clinical or preclinical studies was also evaluated. Thus, our specific aim is to highlight such scientifically validated bioactive compounds having anti-mycobacterial and immunomodulatory activity for future use as medicine or adjunct-therapeutic molecule for TB management.
机译:结核病是人类文明中最致命的传染病之一。全球约有三分之一的人口潜伏感染结核病原体结核分枝杆菌(M.tb)。抗结核抗生素的发现导致结核病死亡率下降。然而,抗生素耐药性结核杆菌株的进化和不同免疫功能低下疾病的卷土重来再次提高了结核病的死亡率。世卫组织已经告诫结核病流行国家出现大流行的可能性,直到发现新的抗结核药物,即当务之急。分析结核病的发病机制,发现结核分枝杆菌通过改变免疫反应的平衡来逃避宿主,并通过杀死细胞或产生炎症来影响宿主。在前抗生素时代,传统药物只是治疗包括结核病在内的不同传染病的措施。印度的古代文献或丰富的印度传统知识和民族医学实践是使用不同本土植物治疗结核病的证据。然而,根据现代科学方法,这些植物及其生物活性分子的抗结核作用尚未彻底确定。在这篇综述中,重点研究了不同传统使用的印度民族药用植物的五种生物活性分子,用于治疗结核病或结核病样症状。这些化合物也通过现代科学方法的正确鉴定及其作用方式进行了验证。在临床或临床前研究中,还评估了这些分子对敏感或耐药结核病原体的有效性。因此,我们的具体目标是强调这种经过科学验证的具有抗分枝杆菌和免疫调节活性的生物活性化合物,以备将来用作结核病管理的药物或辅助治疗分子。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号